AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.1200
-0.0100 (-7.69%)
At close: Mar 28, 2025, 4:00 PM
0.1279
+0.0079 (6.58%)
After-hours: Mar 28, 2025, 7:48 PM EST

AIM ImmunoTech Market Cap

AIM ImmunoTech has a market cap or net worth of $7.65 million as of March 31, 2025. Its market cap has decreased by -56.51% in one year.

Market Cap
7.65M
Enterprise Value
6.68M
1-Year Change
-56.51%
Ranking
Category
Stock Price
$0.12

Market Cap Chart

Since December 1, 1998, AIM ImmunoTech's market cap has decreased from $159.00M to $7.65M, a decrease of -95.19%. That is a compound annual growth rate of -10.88%.

History

DateMarket Cap% Change
Mar 28, 20258.70M-30.95%
Dec 31, 202412.60M-41.40%
Dec 29, 202321.50M43.33%
Dec 30, 202215.00M-65.91%
Dec 31, 202144.00M-39.56%
Dec 31, 202072.80M1,517.78%
Dec 31, 20194.50M-48.28%
Dec 31, 20188.70M-20.91%
Dec 29, 201711.00M-33.73%
Dec 30, 201616.60M-16.58%
Dec 31, 201519.90M-60.20%
Dec 31, 201450.00M12.61%
Dec 31, 201344.40M17.15%
Dec 31, 201237.90M43.56%
Dec 30, 201126.40M-60.42%
Dec 31, 201066.70M-10.23%
Dec 31, 200974.30M166.31%
Dec 31, 200827.90M-50.18%
Dec 31, 200756.00M-59.97%
Dec 29, 2006139.90M19.27%
Dec 30, 2005117.30M24.79%
Dec 31, 200494.00M10.33%
Dec 31, 200385.20M24.74%
Dec 31, 200268.30M-50.29%
Dec 31, 2001137.40M-2.21%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings